An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Endotext [Internet].
Feingold KR, Adler RA, Ahmed SF, et al., editors.
South Dartmouth (MA): MDText.com, Inc.; 2000-.
Top results in this bookTable of Contents
StatPearls [Internet].
Treasure Island (FL): StatPearls Publishing; 2026 Jan-.
Screening for Intermediate Risk Factors for Coronary Heart Disease [Internet].
Helfand M, Buckley D, Fleming C, et al.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2009 Oct. (Evidence Syntheses, No. 73.)
Prevention and Treatment of Atherosclerosis: Improving State-of-the-Art Management and Search for Novel Targets [Internet].
von Eckardstein A, Binder CJ, editors.
Cham (CH): Springer; 2022.
Lomitapide (Juxtapid) [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2015 Jul.
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet].
York (UK): Centre for Reviews and Dissemination (UK); 1995-.
Inclisiran (Leqvio): Therapeutic area: Primary hypercholesterolemia: Reimbursement Review [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2024 Dec.
GeneReviews® [Internet].
Adam MP, Bick S, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2026.
Systematic Review of Cardiovascular Disease Risk Assessment Tools [Internet].
Matheny M, McPheeters ML, Glasser A, et al.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 May. (Evidence Syntheses/Technology Assessments, No. 85.)
Women’s Health Research: Progress, Pitfalls, and Promise.
Institute of Medicine (US) Committee on Women's Health Research.
Washington (DC): National Academies Press (US); 2010.
Stroke [Internet].
Dehkharghani S, editor.
Brisbane (AU): Exon Publications; 2021 Jun 18.
Identifying Signals for Updating Systematic Reviews: A Comparison of Two Methods [Internet].
Shekelle PG, Newberry SJ, Wu H, et al.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Jun.
Mechanisms of Vascular Disease: A Reference Book for Vascular Specialists [Internet].
Fitridge R, Thompson M, editors.
Adelaide (AU): University of Adelaide Press; 2011.
NIEHS Report on the In Vivo Repeat Dose Biological Potency Study of Isodecyl Diphenyl Phosphate (CASRN 29761-21-5) in Male Sprague Dawley (Hsd:Sprague Dawley® SD®) Rats (Gavage Studies): NIEHS Report 04 [Internet].
Auerbach SS, Behl MV, Collins BJ, et al.
Research Triangle Park (NC): National Institute of Environmental Health Sciences; 2022 Oct.
Testosterone and Aging: Clinical Research Directions.
Institute of Medicine (US) Committee on Assessing the Need for Clinical Trials of Testosterone Replacement Therapy; Liverman CT, Blazer DG, editors.
Washington (DC): National Academies Press (US); 2004.
NIEHS Report on the In Vivo Repeat Dose Biological Potency Study of Tricresyl Phosphate (CASRN 1330-78-5) in Male Sprague Dawley (Hsd:Sprague Dawley® SD®) Rats (Gavage Studies): NIEHS Report 06 [Internet].
Evolocumab (Repatha): Therapeutic area: Primary hyperlipidemia: Reimbursement Review [Internet].
Evolocumab (Repatha): Indication: Repatha is indicated for the reduction of elevated low-density lipoprotein cholesterol in adult patients with primary hyperlipidemia (including heterozygous familial hypercholesterolemia and atherosclerotic cardiovascular disease): as an adjunct to diet and statin therapy, with or without other lipid-lowering therapies, in patients who require additional lowering of low-density lipoprotein cholesterol as an adjunct to diet, alone or in combination with non-statin lipid-lowering therapies, in patients for whom a statin is contraindicated: CADTH Reimbursement Recommendation [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2024 Aug.
Comparative Evidence Between Transdermal and Oral Menopausal Hormone Therapy: Drugs [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2025 Apr.
Optimal strategies for monitoring lipid levels in patients at risk or with cardiovascular disease: a systematic review with statistical and cost-effectiveness modelling.
Perera R, McFadden E, McLellan J, et al.
Southampton (UK): NIHR Journals Library; 2015 Dec. (Health Technology Assessment, No. 19.100.)
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on